What is the future for covid drugs and treatments?

Abstract

Mun-Keat Looi reports on where research is focused and what’s missing from the covid treatment pipeline

What do we know about covid in immunocompromised people?

“…But as drug resistance is an ever growing worry, combination treatments seem a likely avenue for immediate exploration 14. One small scale trial has found that a combination of remdesivir and nirmatrelvir-ritonavir with monoclonal antibodies induced a good clinical response in immunocompromised patients with prolonged or relapsed covid-19.…”